A A Ezzat

Summary

Affiliation: King Faisal Specialist Hospital and Research Centre
Country: Saudi Arabia

Publications

  1. pmc Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience
    Naser Elkum
    Department of Biostatistics, Epidemiology, and Scientific Computing, King Faisal Specialist Hospital and Research Center, PO Box 3354, Riyadh 11211, Saudi Arabia
    BMC Cancer 7:222. 2007
  2. ncbi request reprint Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial
    A A Ezzat
    Departments of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
    Med Oncol 17:39-46. 2000
  3. ncbi request reprint High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin
    A A Ezzat
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
    Breast Cancer Res Treat 62:237-44. 2000
  4. pmc Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients
    A A Ezzat
    Department of Oncology MBC64, King Faisal Specialist Hospital and Research Center, PO Box 3354, Riyadh 11211, Kingdom of Saudi Arabia
    Br J Cancer 90:968-74. 2004
  5. ncbi request reprint Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Ann Oncol 10:1441-9. 1999
  6. ncbi request reprint Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Ann Oncol 12:53-8. 2001
  7. ncbi request reprint Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients
    A A Ezzat
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, PO Box 3354, Riyadh, 11211, Saudi Arabia
    Head Neck 23:547-58. 2001
  8. ncbi request reprint Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, Kingdom of Saudi Arabia
    Med Oncol 17:293-300. 2000

Collaborators

  • E M Ibrahim
  • S Bazarbashi
  • Naser Elkum
  • Said Dermime
  • Adher Alsayed
  • Taher Al-Tweigeri
  • Osama Al Malik
  • Ali Al-Zahrani
  • Dahish Ajarim
  • Asma Tulbah
  • Mohamed Alshabanah

Detail Information

Publications8

  1. pmc Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience
    Naser Elkum
    Department of Biostatistics, Epidemiology, and Scientific Computing, King Faisal Specialist Hospital and Research Center, PO Box 3354, Riyadh 11211, Saudi Arabia
    BMC Cancer 7:222. 2007
    ..4% of all female breast cancers comparing to 6.5% in the USA. Breast cancer in young patients is often associated with a poorer prognosis, but there has been a scarcity of published data in the Middle East population...
  2. ncbi request reprint Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial
    A A Ezzat
    Departments of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
    Med Oncol 17:39-46. 2000
    ..We hypothesized that adding high-dose tamoxifen, which is known to have multiple drug resistance-modulatory effects, to the CHOP regimen could increase the response rate, and consequently enhance the survival of patients with NHL...
  3. ncbi request reprint High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin
    A A Ezzat
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia
    Breast Cancer Res Treat 62:237-44. 2000
    ..In an earlier study, we have demonstrated a high response rate in metastatic breast cancer using paclitaxel (P) and cisplatin (C). A phase II study using the same regimen (PC) has been conducted in locally advanced breast cancer (LABC)...
  4. pmc Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients
    A A Ezzat
    Department of Oncology MBC64, King Faisal Specialist Hospital and Research Center, PO Box 3354, Riyadh 11211, Kingdom of Saudi Arabia
    Br J Cancer 90:968-74. 2004
    ..PC was acceptably safe. Neoadjuvant PC as used in this phase II study in a multidisciplinary strategy was highly effective. Clinical and pathologic responses remain the most important variables that predict outcome...
  5. ncbi request reprint Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Ann Oncol 10:1441-9. 1999
    ..This has prompted the analysis of a large series of patients with PG-NHL having high-grade diffuse large B-cell lymphoma (DLCL) in order to define the clinical features and outcome of this disease...
  6. ncbi request reprint Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Ann Oncol 12:53-8. 2001
    ..This has prompted the analysis of another series of patients with primary intestinal DLCL to depict the clinical features and the outcome of that disease and to compare those with that for PG involvement...
  7. ncbi request reprint Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients
    A A Ezzat
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, PO Box 3354, Riyadh, 11211, Saudi Arabia
    Head Neck 23:547-58. 2001
    ..Primary tonsillar site and the low-risk group of the modified IPI predicted favorable OS and EFS. CMT is probably superior to single modality treatment; however, prospective studies are warranted...
  8. ncbi request reprint Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate
    E M Ibrahim
    Department of Oncology, King Faisal Specialist Hospital and Research Centre, Kingdom of Saudi Arabia
    Med Oncol 17:293-300. 2000
    ..Despite that this series included a relatively young population with a high fertility rate, the study confirmed the lack of a survival difference between patients with PABC and their matched controls...